See also this year's filing and all EDGAR filings for this company.
PDF Report 0001750284_2023_Olema_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001750284, Olema Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 208,899,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,480,000 |
| 3 | remainder_Assets | 5,266,000 |
| 4 | LiabilitiesCurrent | 16,549,000 |
| 5 | LiabilitiesNoncurrent | 1,550,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,714,000 |
| 9 | ResearchAndDevelopmentExpense | 82,274,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,201,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,664,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 215,645,000 |
| 1 | Liabilities | 18,099,000 |
| 2 | Expenses | 106,988,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 197,546,000 |
| 5 | NetIncome | -104,787,000 |
| 6 | ComprehensiveNetIncome | -105,619,000 |
| 7 | BaseVar | 172,298,500 |
| 8 | EconomicCapitalRatio | 2.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
